Daily walnut consumption effects lipid profile and body protein in Korean subjects with metabolic syndrome.
The objective of current study was to assess the gender differences on the lipid profiles, apoprotein B, and body composition among the subjects with metabolic syndrome after daily walnut intake (45 g) for 16 weeks. 89 participants (44 men, 40±6.2yr) with metabolic syndrome were screened if they meet at least three metabolic syndrome components out […]
The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: comparison between normoweight, overweight-obesity and metabolic syndrome.
BACKGROUND & AIMS: Urolithins are microbial metabolites produced after consumption of ellagitannin-containing foods such as pomegranates and walnuts. Parallel to isoflavone-metabolizing phenotypes, ellagitannin-metabolizing phenotypes (urolithin metabotypes A, B and 0; UM-A, UM-B and UM-0, respectively) can vary among individuals depending on their body mass index (BMI), but correlations between urolithin metabotypes (UMs) and cardiometabolic risk […]
In-vitro evaluation of the availability of ϖ-3 and ϖ-6 fatty acids and tocopherols from microencapsulated walnut oil.
Among the nuts, walnut is characterized by its important amount of oil (60–65% of flesh weight). The oil extracted from walnut exhibits high contents of polyunsaturated fatty acids ϖ-6 (linoleic acid) and ϖ-3 (linolenic acid), as well as relevant amounts of tocopherols (vitamin E). However, the addition of this type of oil in processed food […]